Kapruvia
*Company:
Vifor Pharma UK LimitedStatus:
No Recent UpdateLegal Category:
Product subject to restricted prescription (C)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 20 August 2024
File name
EU1 22 1643 1-2 _SPC v3 [clean].pdf
Reasons for updating
- Change to paediatric information
Legal category:Product subject to restricted prescription (C)
Updated on 20 August 2024
File name
EU1 22 1643 1-2 _PIL v3.pdf
Reasons for updating
- Change to date of revision
Updated on 20 August 2024
File name
EU1 22 1643 1-2 _SPC v3.pdf
Reasons for updating
- Change to paediatric information
Legal category:Product subject to restricted prescription (C)
Updated on 24 October 2022
File name
Kapruvia IE PIL July 2022.pdf
Reasons for updating
- Correction of spelling/typing errors
Updated on 24 October 2022
File name
Kapruvia_IE SPC_July 2022.pdf
Reasons for updating
- Correction of spelling/typing errors
Legal category:Product subject to restricted prescription (C)
Updated on 09 August 2022
File name
Kapruvia IE SPC July 2022.pdf
Reasons for updating
- Change to section 10 - Date of revision of the text
- Correction of spelling/typing errors
Legal category:Product subject to restricted prescription (C)
Free text change information supplied by the pharmaceutical company
Type IB C.I.z variation: Correction of typos + editorial changes
Updated on 09 August 2022
File name
Kapruvia IE PIL July 2022.pdf
Reasons for updating
- Change to improve clarity and readability
- Change to date of revision
Updated on 16 May 2022
File name
Kapruvia_IE SPC_May 2022.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to restricted prescription (C)
Updated on 10 May 2022
File name
kapruvia IE PIL May 2022.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
New Irish PIL for recently approved product.
Updated on 10 May 2022
File name
Kapruvia_IE SPC_May 2022.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to restricted prescription (C)
Free text change information supplied by the pharmaceutical company
New Irish SPC of recently approved product.